HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of a single intravenous administration of laninamivir (an active metabolite of laninamivir octanoate) in an influenza virus infection mouse model.

Abstract
Laninamivir, a potent neuraminidase (NA) inhibitor, is an active metabolite of laninamivir octanoate (code name: CS-8958) which is a long acting NA inhibitor and is commercially available under the brand name Inavir in Japan to complete the treatment of influenza by a single inhalation. It is supposed that the long acting character is provided by the long retention of laninamivir in the respiratory tract after intranasal administration of laninamivir octanoate in mice and with stable binding of laninamivir to NA of various influenza viruses such as N1, N2 subtypes and NA of B virus. Peramivir, another NA inhibitor, is also approved in Japan as a single intravenous infusion. In spite of the quick disappearance of peramivir from the blood after injection, the reason treatment can be completed by a single administration is thought to be that peramivir showed stable binding to NA with N9 subtype. Therefore, the stable binder, laninamivir is possibly effective by a single intravenous administration in the mouse model infected with influenza viruses. A single intravenous administration of laninamivir and peramivir at 30mg/kg significantly prolonged mice survival at a comparable level in the mouse lethal model infected with the A/PR/8/34 (H1N1) virus. Also, a single intravenous administration of laninamivir and peramivir significantly suppressed virus proliferation in the lungs of mice infected with influenza B virus. Thus, laninamivir may be effective by a single intravenous infusion in treating influenza, the same as peramivir.
AuthorsMasayo Kakuta, Shuku Kubo, Mikiko Tanaka, Satoko Tobiume, Takanori Tomozawa, Makoto Yamashita
JournalAntiviral research (Antiviral Res) Vol. 100 Issue 1 Pg. 190-5 (Oct 2013) ISSN: 1872-9096 [Electronic] Netherlands
PMID23954190 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Antiviral Agents
  • Guanidines
  • Pyrans
  • Sialic Acids
  • laninamivir
  • Zanamivir
Topics
  • Administration, Intravenous
  • Animals
  • Antiviral Agents (administration & dosage)
  • Disease Models, Animal
  • Female
  • Guanidines
  • Humans
  • Influenza A Virus, H1N1 Subtype (drug effects, physiology)
  • Influenza B virus (drug effects, physiology)
  • Influenza, Human (drug therapy, virology)
  • Mice
  • Mice, Inbred BALB C
  • Pyrans
  • Sialic Acids
  • Zanamivir (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: